Officer received an award of 2,560 HCA derivative securities | OQRO Insider tradesWhy it stands out
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Jan 29, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Feb 2, 2026
OfficerGrant / award
Context
- Classification
grant award
Code A — grant or award
- Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001193125-26-034009
- Filed / recorded
Feb 2, 2026, 11:50 PM UTCAdded to OQROOct 2, 2026, 12:28 PM UTC Data qualityVerified: identifiers matched exactly IssuerHCA Healthcare, Inc. Reporting personChristopher F. Wyatt Officer titleSVP & Controller SecurityStock Appreciation Right TableDerivative (Table II) Transaction dateJan 29, 2026 Acquired / disposedAcquired (A) Footnotes from the filing
- The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027.
Around the same time
Derivative exercise or conversion — not an open-market buy.
Routine share withholding; mechanical by default.
HCA Healthcare's & Chief Legal & Admin Off. sold $904K of HCA Healthcare shares. Nobody planned it ahead of time.